Wird geladen...
Fluoxetine for adults who are overweight or obese
BACKGROUND: Fluoxetine is a serotonin reuptake inhibitor indicated for major depression. It is also thought to affect weight control: this seems to happen through appetite changes resulting in decreased food intake and normalisation of unusual eating behaviours. However, the benefit‐risk ratio of th...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2019
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6792438/ https://ncbi.nlm.nih.gov/pubmed/31613390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011688.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|